Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

Author:

Golshan Mehra1,Loibl Sibylle2,Wong Stephanie M.3,Huober Jens Bodo4,O’Shaughnessy Joyce5,Rugo Hope S.6,Wolmark Norman7,McKee Mark D.8,Maag David8,Sullivan Danielle M.8,Metzger-Filho Otto1,Von Minckwitz Gunter4,Geyer Charles E.9,Sikov William M.10,Untch Michael11

Affiliation:

1. Department of Surgery, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Boston, Massachusetts

2. Department of Medical Oncology, German Breast Group, Neu-Isenburg, Germany

3. Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada

4. Department of Medical Oncology, University of Ulm, Ulm, Germany

5. Department of Medical Oncology, Texas Oncology–Baylor Sammons Cancer Center, US Oncology, Dallas

6. Department of Medical Oncology, University of California, San Francisco

7. Department of Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania

8. AbbVie, Inc, North Chicago, Illinois

9. Department of Medical Oncology, Virginia Commonwealth University Massey Cancer Center, Richmond

10. Department of Medical Oncology, Women and Infants Hospital of Rhode Island, Providence

11. Department of Breast Surgery, Helios Klinikum Berlin-Buch, Berlin, Germany

Publisher

American Medical Association (AMA)

Subject

Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3